Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by S100A4 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. Zusätzlich bieten wir Ihnen s100a4 Proteine (37) und s100a4 Kits (35) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 244 products:
Human Monoclonal s100a4 Primary Antibody für IF, ELISA - ABIN562767
Nishioku, Furusho, Tomita, Ohishi, Dohgu, Shuto, Yamauchi, Kataoka: Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. in Neuroscience 2011
Show all 5 Pubmed References
Human Polyclonal s100a4 Primary Antibody für IHC (p), IHC - ABIN188680
Jiang, Xu, Mao, Li, Fang, Zhou, Liu, He, Zhao, Yang, Dai: Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. in Journal of the American Society of Nephrology : JASN 2013
Show all 2 Pubmed References
Human Polyclonal s100a4 Primary Antibody für IHC, IHC (p) - ABIN4351669
Laguë, Detmar, Paquet, Boyer, Richards, Adamson, Boerboom: Decidual PTEN expression is required for trophoblast invasion in the mouse. in American journal of physiology. Endocrinology and metabolism 2010
Show all 2 Pubmed References
Human Polyclonal s100a4 Primary Antibody für IHC, ELISA - ABIN334485
Li, Bresnick: The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. in Cancer research 2006
Show all 2 Pubmed References
Human Polyclonal s100a4 Primary Antibody für ELISA, WB - ABIN562766
Chen, Wang, Wu, Su, Hong, Chuang, Chen, Hua, Wu, Cha, Babu, Chen, Lee, Chang, Kuo: CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. in Journal of cell science 2007
S100A4-expression was associated with poor outcome in early-stage breast cancer, but the low percentage of positive tumors and the modest survival differences imply that the clinical utility in selection of patients for adjuvant treatment is limited.
The relative expression of S100A4 mRNA was higher when mod (zeige MOD(MDG4) Antikörper)-SHEM was used, although significant differences were detected only when the expression levels were compared with those found in LPCs incubated with IOBA-FBS (zeige FBXO8 Antikörper)
High S100A4 expression is associated with Mesenchymal Transition in Glioblastoma.
our findings demonstrate that S100A4 is post-transcriptionally regulated by tumor suppressor microRNAs
findings indicate that Idiopathic pulmonary fibrosis mesenchymal progenitor cells are intrinsically fibrogenic and that S100A4 confers mesenchymal progenitor cells with fibrogenicity.
S100a4 is expressed in a limited number of stromal cells throughout the colon. S100A4 was mainly localised in the colorectal tumour-associated stroma, it was also detectable in a limited number of epithelial tumour cells.
our results suggest the existence of evolutionarily conserved pathways used by S100A4 to promote metastatic dissemination
miR (zeige MLXIP Antikörper)-187-3p inhibits the migration/metastasis and epithelial mesenchymal transition in hepatocellular carcinoma by targeting S100A4 expression.
our findings highlight nuclear S100A4 as a candidate therapeutic target in cholangiocarcinoma and establish a mechanistic rationale for the use of low-dose paclitaxel in blocking metastatic progression of cholangiocarcinoma
The increased content of collagen fibers and overexpression of S100A4 and P53 (zeige TP53 Antikörper) may play an important role in myocardial fibrosis of HCM, and they can be used in future HCM research. Blockade of S100A4 may have therapeutic potential in HCM by attenuating cardiac fibrosis.
The Smad3 (zeige SMAD3 Antikörper) and Bmal1 (zeige ARNTL Antikörper) regulate p21 (zeige D4S234E Antikörper) and S100A4 expression in myocardial stromal fibroblasts through TNF-alpha (zeige TNF Antikörper).
Data provide the first report on the in vivo role of S100a4 in intestinal tumourigenesis and describe a new role for S100a4 in the aetiology of desmoids formation.
S100A4 expression protects cardiac myocytes against myocardial ischemia and is required for stabilization of cardiac function after MI.
These findings provide further evidence on extracellular S100A4 as paracrine mediator of prometastatic endothelial dysfunction involving its interaction with RAGE (zeige AGER Antikörper).
this study has demonstrated a crucial role for retinoic acid in promoting IL-22 (zeige IL22 Antikörper) production and tempering dendritic cell function through downregulating S100A4 protein during viral hepatitis
Extracellular S100A4 is important for the regulation of bone formation by activating the NF-kappaB (zeige NFKB1 Antikörper) signaling pathway in osteoblasts.
Interaction of extracellular S100A4 with RAGE (zeige AGER Antikörper) prompts prometastatic activation of melanoma cells.
Our results indicated that RNV was ameliorated by Ad-S100A4-RNAi transfer in a mouse model of OIR through mediation of the anti-apoptotic effect of Bcl-2 (zeige BCL2 Antikörper) by reducing the expression of CREB (zeige CREB1 Antikörper).
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified.
S100 calcium binding protein A4
, S100 calcium-binding protein A4
, S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, fibroblast-specific protein-1
, leukemia multidrug resistance associated protein
, malignant transformation suppression 1
, placental calcium-binding protein
, protein Mts1
, protein S100-A4
, S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, S100 calcium-binding protein A4 (calcium protein,calvasculin, metastasin, murine placental homolog)
, placental calcium-binding protein homolog
, metastatic cell protein
, protein 18A2
, Protein 9 Ka homologous to calcium-binding protein
, nerve growth factor-induced protein 42A